NICE nod for psoriatic arthritis drugs Cimzia and Cosentyx
Cost regulators for the NHS in England and Wales are recommending UCB’s Cimzia and Novartis’ Cosentyx as treatment options for adults with active psoriatic arthritis.
Read More
Tag: TNF-alpha
- MHRA to open new Northern Ireland hub to strengthen UK‑wide life sciences collaboration
- Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial
- Enterprise reports positive phase 2 data for inhaled ENaC blocker in cystic fibrosis
- SMC backs first-line metastatic bladder cancer combination after trial results
- Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS
